Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TIE1 |
|
|
| TEK |
|
|
| DDR1 |
|
|
| DDR2 |
|
|
Selectivity
Potency Cellular
In Vitro
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/jnc.13877
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/jnc.13877
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/jnc.13877
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/jnc.13877
In Vivo Validations
DOI Reference: 10.1111/jnc.13877
Negative Control Compounds
Notes: BAY-309: > 10,000 times less in biochemical assay (TEK (TIE-2)); >100 times less in cellular assay (DDR1/2, STK10, EPHB6); for Tie-1 is only about 30 fold less potent; NanoBRET assay (SGC Frankfurt): TIE1 (EC50 = 2.6 ± 0.55 µM, n=3), TEK (EC50 = 3.3 ± 0.34 µM, n= 3), DDR1 (EC50 = 200 ± 32 nM, n=3), DDR2 (EC50= 2.7 ± 1.2 µM, n=3), STK10 (EC50 = 3.2 ± 0.44 µM, n= 3), EPHB6 (EC50 =27 ± 5.8 µM, n= 3), LYN (EC50 > 50 µM, n= 3) Shows off-target activity in the PDSP scan: Closest hits are GABAA/PBR (pKi = 8.03) and TMEM97 (Sigma2) (pKi = 6.10).
Chemical Information
| Molecular Formula | C26H19F5N6OS |
| SMILEs | Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1 |
| InChI | InChI=1S/C26H19F5N6OS/c1-16-8-17(2)24(36-6-7-37-25(36)13-23(35-37)19-4-3-5-33-15-19)12-22(16)34-26(38)20-9-18(14-32)10-21(11-20)39(27,28,29,30)31/h3-13,15H,1-2H3,(H,34,38) |
| Molecular weight | 558.13 Da |
| AlogP | 7.585220000000003 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 58 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.
